Cargando…

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs †

Cardiovascular disease remains the leading global cause of death. Early intervention, with lifestyle advice alongside appropriate medical therapies, is fundamental to reduce patient mortality among high-risk individuals. For those who live with the daily challenges of cardiovascular disease, pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noyes, James D., Mordi, Ify R., Doney, Alexander S., Jamal, Rahman, Lang, Chim C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396016/ https://www.ncbi.nlm.nih.gov/pubmed/34449608 http://dx.doi.org/10.3390/diseases9030055

Ejemplares similares

Nicorandil‐induced colovesical fistula in a patient with diverticular disease
por: Noyes, James D., et al.
Publicado: (2021)

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
por: Mordi, Ify R., et al.
Publicado: (2020)

Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure
por: Steggall, Abbey, et al.
Publicado: (2017)

Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial
por: Mordi, Natalie A., et al.
Publicado: (2020)

Use of Population-Based Health Informatics Research to Improve Care for Patients with Cardiovascular Diseases
por: Mordi, Ify R., et al.
Publicado: (2020)

COVID-19-Associated Cardiovascular Complications
por: Lee, Clement C. E., et al.
Publicado: (2021)

Computational models for the prediction of adverse cardiovascular drug reactions
por: Jamal, Salma, et al.
Publicado: (2019)

Precision dosing to avoid adverse drug reactions
por: Polasek, Thomas M., et al.
Publicado: (2019)

Genetic and pharmacological relationship between P-glycoprotein and increased cardiovascular risk associated with clarithromycin prescription: An epidemiological and genomic population-based cohort study in Scotland, UK
por: Mordi, Ify R., et al.
Publicado: (2020)

Adverse drug reactions induced by cardiovascular drugs in outpatients
por: Gholami, Kheirollah, et al.
Publicado: (2008)

Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
por: Mordi, Natalie A, et al.
Publicado: (2017)

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

The Detection of Adverse Drug Reactions
por: Crooks, James
Publicado: (1977)

Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
por: Alessandrini, Marco, et al.
Publicado: (2016)

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
por: Kloypan, Chiraphat, et al.
Publicado: (2021)

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)

Monitoring adverse drug reactions in the community settings
por: Ab Rahman, Ab Fatah
Publicado: (2019)

Adverse Drug Reactions
por: Turner, Paul
Publicado: (1988)

Adverse Drug Reactions
por: Criado, Paulo Ricardo
Publicado: (2016)

Precision Medicine: Determination of Ribavirin Urinary Metabolites in Relation to Drug Adverse Effects in HCV Patients
por: Giampaoli, Ottavia, et al.
Publicado: (2022)

The Law in Relation to Unforeseen Adverse Drug Reaction
por: Wilmers, J.
Publicado: (1977)

Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
por: Galletti, Cristiano, et al.
Publicado: (2021)

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine
por: Viswanathan, Thyla, et al.
Publicado: (2021)

Repurposing drugs to treat cardiovascular disease in the era of precision medicine
por: Abdelsayed, Mena, et al.
Publicado: (2022)

Antiepileptic Drug-Related Adverse Reactions and Factors Influencing These Reactions
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity
por: Wiley, Laura K., et al.
Publicado: (2015)

Individualized medicine: Sex, hormones, genetics, and adverse drug reactions
por: Moyer, Ann M., et al.
Publicado: (2019)

Adverse drug reactions in the elderly
por: Brahma, Dhriti K., et al.
Publicado: (2013)

Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes
por: Al-Talabany, Shaween, et al.
Publicado: (2018)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

The combined incremental prognostic value of left ventricular ejection fraction, late gadolinium enhancement and global circumferential strain assessed by cardiovascular magnetic resonance
por: Mordi, Ify, et al.
Publicado: (2015)

Non-Invasive Imaging in Diabetic Cardiomyopathy
por: Mordi, Ify R.
Publicado: (2019)

HLA Association with Drug-Induced Adverse Reactions
por: Fan, Wen-Lang, et al.
Publicado: (2017)

Textbook of adverse drug reactions /
Publicado: (1977)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Textbook of Adverse Drug Reactions
por: George, Charles F.
Publicado: (1992)

MRGPRX2 and Adverse Drug Reactions
por: McNeil, Benjamin D.
Publicado: (2021)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l18katnjl57cutd8feu6crsqt5